ICSID Schedules Hearing On Jurisdiction / Merits In Pharmaceutical Dispute

ICSID Schedules Hearing On Jurisdiction / Merits In Pharmaceutical Dispute

WASHINGTON, D.C. - The International Centre for Settlement of Investment Disputes (ICSID) on Oct. 25 announced that a hearing on jurisdiction and the merits of a dispute in relation to claims asserted by a group of pharmaceutical companies against the United States has been scheduled (Apotex Inc. v. The Government of the United States of America, ICSID).

Access this news story on lexis.com®